4 months after the last intravesical BCG treatment. Thymic histology revealed adipose tissue with rare remnants of benign thymic tissue. He started 100 mg/day of azathioprine immediately after thymectomy, but this was discontinued 2 weeks later because of elevated liver transaminases.
found that miR-19a-3p was upregulated (P = 0.008) and miR-425-5p was downregulated (P = 0.026) in the serum samples of patients with ALS compared with healthy controls, 1 and thus the use of these microRNAs for normalizing cycle threshold values is controversial. Benigni et al. indicated that miR-15b-5p was downregulated in the cerebrospinal fluid samples of patients with ALS (P < 0.0001). 2 Waller et al. also identified miR-15b-5p as a dysregulated microRNA between ALS patients and a noninflammatory neuropathy patient group (P = 0.021). 3 Liguori et al. reported that miR-425-5p was downregulated in the peripheral blood samples of ALS patients. 4 Mouse studies also indicated that this panel of microRNA was not suitable for normalization, as Marcuzzo et al. found that miR-19a expression was significantly decreased in the G93A-SOD1 mouse model of ALS at week 8, whereas miR-19a was upregulated at week 18 compared with control mice (P < 0.05). 5 Based on the studies described herein, we conclude that the panel of microRNA used for normalization in the study by Raheja et al. may not be suitable.
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STUDY OF SERUM MICRORNA EXPRESSION IN AMYOTROPHIC LATERAL SCLEROSIS PATIENTS: THE CHALLENGE OF SELECTING SUITABLE INTERNAL CONTROL FOR NORMALIZATION
Thank you for giving us the opportunity to respond to Dr. Madadi and Dr. Soleimani. Several studies have focused on identifying differential miRNA expression in disease versus healthy controls. The outcomes of analyses such as our study depend on numerous factors including the normalization process. Currently, there are no universally accepted "housekeeping" reference transcripts for microRNA (miRNA) normalization. Accordingly, standard endogenous controls for the normalization of miRNA levels in serum have not been established, and various studies adopt different normalization strategies.
Several miRNAs have been proposed for use as normalizers such as RNU6 and small nucleolar RNAs. In certain cases, a synthetic nonprimate miRNA is frequently spiked in during RNA isolation to correct for technical variations in RNA recovery. In circulating miRNAs, unlike cellular miRNAs, tRNA and rRNA expression is too low and normalization using their expression values is less accurate. NormFinder is a software that identifies the optimal normalizer using a model-based variance estimation approach and can be applied to any experimental design. The lower the stability value (SV) calculated with this model, the higher the stability of the normalizer. 1 In addition, Exiqon data analysis support also provided the suggestion regarding the use of a combination of the most stable miR-NAs as normalizers. We have used this approach in other publications. 2, 3 More importantly, in these published studies, we corroborated our findings with these normalizers using other normalization techniques.
The authors point out that some of the miRNAs that we have chosen as normalizers (miR-15b-5p and miR-19a) are differentially expressed in other studies in humans and mice. It is important to note that several factors contribute to the expression of miRNAs and their stability index on algorithms such as Norm-Finder including tissue type, species, method of recovery, sample size, and technique used for miRNA detection. 4 Therefore, we believe that their appearance in other studies does not mean that they are unsuitable to use as normalizers in our study.
For our study, we selected our candidate normalizers (miR-15b-5p, miR19a-3p, miR-126-3p, miR-425-5p) using NormFinder. The choice of these normalizers was made before performing any of the group comparisons or analyses in the study. While it is possible that the results might have changed with alternative normalizers, these differences would provide further evidence that identifying universal normalizers for circulating miRNAs is a critical challenge in the field, and discovery studies in smaller cohorts should be validated in larger groups to make meaningful biological and clinical interpretations.
